117 related articles for article (PubMed ID: 27611086)
41. c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.
Refaat T; Donnelly ED; Sachdev S; Parimi V; El Achy S; Dalal P; Farouk M; Berg N; Helenowski I; Gross JP; Lurain J; Strauss JB; Woloschak G; Wei JJ; Small W
Am J Clin Oncol; 2017 Dec; 40(6):590-597. PubMed ID: 26083558
[TBL] [Abstract][Full Text] [Related]
42. Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer.
Wang W; Shi Y; Li J; Cui W; Yang B
Biosci Rep; 2016; 36(2):. PubMed ID: 27128470
[TBL] [Abstract][Full Text] [Related]
43. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
44. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
45. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
46. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
48. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
49. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
[TBL] [Abstract][Full Text] [Related]
50. CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.
Tanaka T; Terai Y; Kogata Y; Ashihara K; Maeda K; Fujiwara S; Yoo S; Tanaka Y; Tsunetoh S; Sasaki H; Kanemura M; Tanabe A; Ohmichi M
Oncol Rep; 2015 Nov; 34(5):2282-8. PubMed ID: 26351781
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix.
Tjalma W; Weyler J; Goovaerts G; De Pooter C; Van Marck E; van Dam P
J Clin Pathol; 1997 Jan; 50(1):33-6. PubMed ID: 9059353
[TBL] [Abstract][Full Text] [Related]
52. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
54. Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer.
Kim BW; Cho H; Ylaya K; Kitano H; Chung JY; Hewitt SM; Kim JH
Anticancer Res; 2017 Sep; 37(9):4873-4879. PubMed ID: 28870908
[TBL] [Abstract][Full Text] [Related]
55. Correlations of p53 expression with transvaginal color Doppler ultrasound findings of cervical cancer after radiotherapy.
Wang P; Sun W; Wang L; Gao J; Zhang J; He P
J BUON; 2018; 23(3):769-775. PubMed ID: 30003750
[TBL] [Abstract][Full Text] [Related]
56. p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis.
Bremer GL; Tieboschb AT; van der Putten HW; de Haan J; Arends JW
Eur J Obstet Gynecol Reprod Biol; 1995 Nov; 63(1):55-9. PubMed ID: 8674566
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive Identification of the Human Secretome as Potential Indicators in Treatment Outcome of HPV-Positive and -Negative Cervical Cancer Patients.
Kong L; Wang J; Cheng J; Zang C; Chen F; Wang W; Zhao H; Wang Y; Wang D
Gynecol Obstet Invest; 2020; 85(5):405-415. PubMed ID: 33171469
[TBL] [Abstract][Full Text] [Related]
58. The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis.
Yan R; Shuai H; Luo X; Wang X; Guan B
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28883082
[TBL] [Abstract][Full Text] [Related]
59. The clinical significance of HPIP and the associated prognosis in cervical cancer.
Meng F; Liu H; Liu S; Ma R
Oncotarget; 2017 Sep; 8(41):70262-70270. PubMed ID: 29050277
[TBL] [Abstract][Full Text] [Related]
60. LNMICC Promotes Nodal Metastasis of Cervical Cancer by Reprogramming Fatty Acid Metabolism.
Shang C; Wang W; Liao Y; Chen Y; Liu T; Du Q; Huang J; Liang Y; Liu J; Zhao Y; Guo L; Hu Z; Yao S
Cancer Res; 2018 Feb; 78(4):877-890. PubMed ID: 29229603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
